On the other hand, it is noteworthy that the endogenous prostaglandin 15d-PGJ2 mediates many of the anti-inflammatory actions associated with activation of PPAR-γ (45, 46) and might be a safer therapy for asthma patients as compared with synthetic PPAR-γ agonists. This evidence concerns the gene PPARG and asthma.